Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Venetoclax Plus Decitabine in Elderly/Unfit Patients With Newly Diagnosed AML: A Multicenter Single-Arm Study

NCT07117422 is registered in ClinicalTrials.gov with The Second Hospital of Hebei Medical University as lead sponsor.

NCT NCT07117422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07117422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Venetoclax Plus Decitabine in Elderly/Unfit Patients With Newly Diagnosed AML: A Multicenter Single-Arm Study
Lead sponsor
The Second Hospital of Hebei Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
January 17, 2025
Completion date
January 30, 2027
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult